Mark D. Tyson, II, MD, MPH, reviews emerging bladder-sparing therapies for NMIBC, highlighting cretostimogene data, treatment sequencing, and the need for comparative trials. Peter Clark, MD, ...
A national study found that use of MRI before prostate biopsy increased in US hospitals from 2017 through the first half of 2026. Lorelei A. Mucci, ScD, MPH, discusses the evolving evidence ...
Farah Rahman, MD, MPH, highlights a pilot study on the use of wearable biofeedback technology to better understand and address burnout among urology residents. Sudha Jayaraman, MD, MSc, FACS, recaps a ...
"If a high percentage of the radicals are billed with urethral suspension, then it is likely to be bundled in the future and it is possible that it will be tagged with an indicator that will not allow ...
The FDA authorized an Expanded Access Program for NAI to manage lymphopenia in refractory or relapsed solid tumor patients. ImmunityBio’s Cancer BioShield platform enhances NK and T cell proliferation ...
In the final installment in a 5-part series, Richard Wassersug, PhD, and Paul F. Schellhammer, MD, FACS, discuss strategies for establishing transdermal estradiol as a recognized therapy for men ...
Bel-sar demonstrated promising efficacy and safety in NMIBC, with complete clinical responses in most low-grade disease patients. The treatment induces tumor cell necrosis and pro-immunogenic cell ...
The ZIRCON trial reported high accuracy of TLX250-CDx in detecting and characterizing ccRCC in patients with indeterminate renal masses. Data from the phase 3 ZIRCON trial (NCT03849118) evaluating ...
Clinical research has demonstrated a 10-minute onset interval for the topical gel formulation MED3000, compared to an interval of at least 30 minutes with PDE5 inhibitors, such as Cialis and Viagra.
"The patient’s counsel alleged that the urologist had failed to properly inform the patient of the risks and complications associated with the treatment," writes Acacia Brush Perko, Esq. On August 22, ...
In this interview, Robert Reiter, MD, MBA, discusses the accuracy of PSMA-PET scans, false negative and false positive rates, and how treatment with ADT affects PSMA uptake. Prostate-specific membrane ...
The Glean Urodynamics System offers wireless, catheter-free monitoring, improving accuracy and comfort for LUTD patients. Developed with the Cleveland Clinic, the system allows natural voiding, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results